The Barry Callebaut Group, the world’s leading manufacturer of high-quality chocolate and cocoa products, announced today its intention to acquire and integrate the chocolate production facility of Mondelēz International in Halle, Belgium.
Mondelēz International would enter into an agreement with Barry Callebaut for the long-term supply of 30,000 tonnes of liquid chocolate per annum. Under a toll-manufacturing agreement, Barry Callebaut would make certain consumer products for Mondelēz International that are currently produced at the chocolate plant in Halle.
As a result of this transaction, Barry Callebaut would be better equipped to capture business opportunities in the fast growing segment of specialty chocolate and fillings “Made in Belgium”.
CEO Antoine de Saint-Affrique said: “This is an excellent opportunity for Barry Callebaut to strengthen our global strategic supply partnership with Mondelēz International. As a result, we would also be able to expand our manufacturing capacity for quality Belgian chocolate needed to support the continuous growth of our business with both Food Manufacturers and Gourmet & Specialties customers. This all demonstrates our continued commitment to Belgium and reflects the excellent reputation that Belgian chocolate enjoys globally.”
The expected closing of the transaction is by the end of December 2016, after completing works council consultation. The transaction is subject to closing conditions. The two parties have agreed not to disclose any financials of the transaction.
Source: Barry Callebaut Group
The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.
The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.
Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.
